Insider: REED ELIZABETH E Chief Legal Officer and GC - Travere Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 105,211 | 0 | 105,211 |
| Value | $3,202,622.84 | $0.00 | $3,202,622.84 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/16/2026 | DDS | 10,000 | Direct | COM | $28.09 | $280,861.00 | 105,211 |
| 02/17/2026 | DDS | 5,679 | Direct | COM | $27.50 | $156,195.22 | 109,532 |
| 02/17/2026 | DDS | 4,321 | Direct | COM | $28.26 | $122,120.10 | 105,211 |
| 02/04/2026 | DDS | 2,485 | Direct | COM | $32.07 | $79,693.95 | 105,720 |
| 02/04/2026 | DDS | 509 | Direct | COM | $32.74 | $16,664.66 | 105,211 |
| 02/03/2026 | DDS | 7,175 | Direct | COM | $32.12 | $230,461.00 | 108,205 |
| 01/20/2026 | DDS | 10,000 | Direct | COM | $27.34 | $273,420.00 | 90,270 |
| 09/22/2025 | DDS | 10,000 | Direct | COM | $25.00 | $250,000.00 | 89,878 |
| 05/05/2025 | DDS | 4,920 | Direct | COM | $21.05 | $103,566.00 | 89,482 |
| 02/12/2025 | DDS | 8,000 | Direct | COM | $23.53 | $188,240.00 | 89,482 |
| 02/03/2025 | DDS | 8,951 | Direct | COM | $19.78 | $177,050.78 | 89,482 |
| 01/22/2025 | DDS | 2,437 | Direct | COM | $19.46 | $47,424.02 | 76,933 |
| 09/09/2024 | DDS | 4,387 | Direct | COM | $11.52 | $50,538.24 | 78,633 |
| 02/01/2024 | DDS | 2,590 | Direct | COM | $8.86 | $22,947.40 | 76,270 |
| 02/01/2024 | DDS | 2,174 | Direct | COM | $8.53 | $18,547.92 | 78,860 |
| 01/23/2024 | DDS | 2,062 | Direct | COM | $8.96 | $18,475.52 | 56,034 |
| 09/05/2023 | DDS | 1,815 | Direct | COM | $14.71 | $26,698.65 | 58,096 |
| 05/10/2023 | DDS | 825 | Direct | COM | $16.59 | $13,686.75 | 56,611 |
| 02/01/2023 | DDS | 2,590 | Direct | COM | $22.25 | $57,627.50 | 57,436 |
| 01/24/2023 | DDS | 2,062 | Direct | COM | $21.50 | $44,333.00 | 39,776 |
| 05/12/2022 | DDS | 1,050 | Direct | COM | $21.51 | $22,584.45 | 41,838 |
| 05/10/2022 | DDS | 900 | Direct | COM | $21.51 | $19,359.00 | 42,888 |
| 01/31/2022 | DDS | 1,350 | Direct | COM | $27.40 | $36,990.00 | 43,788 |
| 01/24/2022 | DDS | 2,250 | Direct | COM | $24.98 | $56,205.00 | 35,298 |
| 01/11/2022 | DDS | 5,000 | Direct | COM | $27.40 | $137,000.00 | 37,548 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research